Alternative Protein Market Size & Share 2026-2035

Alternative Protein Market Size

The global alternative protein market was valued at USD 107.6 billion in 2025. The market is projected to reach USD 318.4 billion by 2035, advancing at approximately 10.7% CAGR during 2026–2035.

Alternative proteins encompass plant-derived ingredients, insect meals, microbial and fermentation-derived proteins, and emerging protein platforms that reduce dependence on conventional livestock supply chains. The market is supported by a widening protein requirement: global meat consumption is projected to rise 12% by 2033 against the 2021–2023 baseline, while poultry is expected to account for roughly one-third of global livestock meat production ^{[1]OECD, Meat: OECD-FAO Agricultural Outlook 2024-2033, 2024, oecd.org}. This expansion increases pressure on feed, land, water, and livestock-production systems rather than creating a simple substitution opportunity.

Environmental performance gives alternative proteins a second demand rationale. Comparative assessment indicates that plant-based meats can generate 69–92% fewer greenhouse-gas emissions, require 38–91% less land, and use 53–95% less water than conventional meat ^{[2]Good Food Institute, Comparative Life Cycle Assessment of Plant-Based Meats and Conventional Animal Meats, June 2025, gfi.org}. The commercial relevance depends on the production route. Fermentation-derived protein can offer particularly low land exposure, but its economics remain tied to electricity, feedstock, bioreactor utilization, and downstream recovery. Plant proteins have a more established supply base but still require progress in sensory quality and finished-product pricing.

The market's growth profile is uneven across sources and end uses. Food applications account for most market value because branded food, ingredients, and nutrition formats can capture higher prices than feed ingredients. Feed applications remain strategically important because aquaculture, poultry, swine, and petfood offer large-volume routes for proteins that meet digestibility, palatability, and regulatory requirements. Asia Pacific is expected to lead regional growth, reflecting its scale in food ingredients, aquaculture, and livestock production.

Microbial proteins carry a different risk-reward profile. Their projected 13.2% CAGR reflects the potential to decouple protein production from agricultural land, yet scale economics remain decisive. Published fermentation models show biomass-protein production costs ranging from USD 1.3/kg to USD 18.1/kg, with a median near USD 4.3/kg, compared with approximately USD 1.5–2.0/kg for soy protein concentrate. Companies able to secure low-cost inputs, operate continuously at meaningful scale, and access food or premium-feed markets are therefore better positioned than platforms relying solely on pilot-level technical validation.

Key Drivers

Growing global protein demand amid population growth

Rising protein demand supports alternative proteins most directly where conventional supply faces feed, resource, or import constraints. The European Parliament Research Service estimates that alternative proteins could represent 11% of the global protein food market by 2035 in a base case and up to 22% under an optimistic scenario; it also identifies Asia Pacific as a potential destination for two-thirds of global alternative-protein consumption by that year ^{[3]European Parliament Research Service, Alternative protein sources for food and feed, 2024, europarl.europa.eu}. This points to a market shaped not only by consumer meat substitution, but also by ingredient demand in feed, processed food, and nutrition products.

In feed markets, the protein gap is commercially tangible in aquaculture and young-animal nutrition. Fishmeal substitution, digestible soy derivatives, hydrolyzed yeast, and single-cell protein can address protein-quality requirements where conventional inputs are volatile or supply constrained. In food markets, urbanization and protein fortification are expanding demand beyond branded meat analogs into dairy alternatives, beverages, bakery, and snacks.

Environmental sustainability and climate change mitigation urgency

Alternative proteins gain value when environmental attributes can be translated into procurement requirements, product claims, or lower regulatory exposure. Oxford research estimates that a transition to alternative proteins could reduce food-system emissions by as much as 8 gigatons of CO₂-equivalent annually in a fully renewable energy system; land released from livestock could potentially support substantial carbon sequestration ^{[4]Smith School of Enterprise and the Environment, University of Oxford, The Climate Impact of Alternative Proteins, March 2022, smithschool.ox.ac.uk}. These outcomes are conditional on energy systems and production methods, but they strengthen the case for proteins that reduce land-intensive livestock dependence.

The benefit is not uniform across technologies. Plant proteins generally have a clear current environmental advantage, while microbial proteins depend more heavily on electricity sources and fermentation efficiency. A lifecycle assessment found mycoprotein emissions of approximately 0.8 kg CO₂-equivalent per kilogram of protein, compared with approximately 8.3 kg for pork protein. This creates an advantage for producers that can pair fermentation capacity with low-carbon energy and high asset utilization.

Government investment and policy support acceleration

Public support is shifting from isolated research grants toward infrastructure, regulatory development, and commercialization programs. Government commitments to protein diversification reached approximately USD 2.5 billion across more than 33 countries by 2025, compared with around USD 700 million in 2021. Annual public disbursements reached an estimated USD 560 million in 2024, up from USD 348 million in 2023.

Policy support matters because alternative-protein development requires shared assets that individual firms may not finance efficiently, including pilot infrastructure, food-safety assessment capacity, fermentation research, and scale-up expertise. European programs illustrate this approach: the European Innovation Council allocated EUR 50 million to algae and precision-fermentation scale-up, while the European Investment Bank provided a EUR 20 million loan to Danish biomass-fermentation company MATR Foods. Such programs reduce technical and financing friction, but they do not eliminate the commercial requirement for durable demand and competitive unit costs.

Key Restraints

High production costs and manufacturing scale-up barriers

Cost remains the principal constraint on broad-based adoption. A study across six European countries found that meat substitutes were 24–115% more expensive than conventional meat in five countries, with Germany the only market approaching price parity. The barrier is especially material in price-sensitive food markets, where consumers can easily return to conventional proteins when product differentiation does not justify the premium.

The production challenge varies by source. Plant-based products must combine protein processing, extrusion, flavor management, and distribution economics. Fermentation platforms must optimize titer, yield, productivity, feedstock use, and recovery while deploying capital-intensive equipment. The cost-analysis literature indicates that scale above approximately 2,000 metric tons annually is a meaningful threshold for improved fermentation economics, although technology-specific performance remains more important than a single capacity benchmark.

Insect protein illustrates the consequences of scaling before economics are proven. Ynsect entered judicial recovery in February 2025 after failing to secure the financing needed to reach profitability at its Amiens facility. Its subsequent liquidation highlighted how energy costs, feedstock constraints, and capital intensity can overwhelm regulatory progress when output lacks a sufficient price premium.

Consumer acceptance and taste perception gaps

Taste, texture, and price determine whether alternative proteins move from trial to repeat purchase. In U.S. consumer research, 36% of consumers said they would buy plant-based meat more often if taste and texture matched conventional meat, while 35% identified price parity as a critical condition. NECTAR's sensory evaluation of 45 products across five categories found that only plant-based nuggets achieved statistical taste parity with conventional counterparts among 1,150 omnivore participants.

These findings alter the commercial priority for food manufacturers. Greater retail presence will not necessarily create sustained volume unless formulations perform consistently in familiar use occasions. Companies with ingredient, flavor, texture, and process capabilities can address this constraint more directly than companies focused only on protein supply. In feed, the equivalent requirement is dependable nutritional performance, palatability, and cost per unit of usable protein.

The near-term market will not be defined by a uniform recovery in every plant-based category. It will be shaped by companies that convert technical improvements into price-adjusted value. Starbucks' removal of plant-based milk surcharges in late 2024, alongside foodservice growth in plant-based dairy, demonstrates how pricing architecture can influence adoption more rapidly than broad sustainability messaging. Meanwhile, capital-intensive insect and fermentation platforms must demonstrate that scale improves margins rather than amplifying fixed-cost exposure.

Alternative Protein Market Segment Analysis

By Source

Plant-Based

Plant-based protein is the largest source segment, increasing from USD 76.7 billion in 2025 to USD 219.7 billion by 2035 at approximately 10.3% CAGR. Soy protein isolate and concentrate remain foundational because of their established processing base, protein density, and functionality across food and feed. ADM completed a USD 300 million expansion of its Decatur, Illinois facility in the first quarter of 2025, increasing soy protein concentrate capacity and nearly doubling high-moisture extrusion capacity ^{[5]ADM, ADM to Meet Fast-Growing Demand for Alternative Proteins with Significant Capacity Expansion, New Innovation Center, April 2022, adm.com}.

The source category is broadening beyond soy. Roquette launched NUTRALYS Fava S900M, a 90% fava bean protein isolate, in Europe and North America in May 2024 ^{[6]Roquette, Launch of NUTRALYS Fava S900M – First Fava Bean Protein Isolate, May 2024, roquette.com}. Beneo brought a EUR 50 million faba bean protein-concentrate facility in Offstein, Germany, into operation in the second quarter of 2025. These investments reflect demand for ingredients with different allergen, taste, texture, and supply-chain characteristics rather than a straightforward replacement of soy.

Duckweed illustrates the role of authorization in creating narrow but potentially valuable market openings. The European Commission authorized protein concentrate from *Lemna gibba* and *Lemna minor* as a novel food in April 2024, with exclusivity for the applicant through April 2029. Such exclusivity can support early commercialization, although it also limits near-term category competition.

Soy Protein Isolates represent the most refined form of soy-derived plant protein, with protein concentration exceeding 90% on a dry basis, commanding a premium over concentrates due to superior digestibility, neutral flavor profile, and functional versatility in dairy alternatives, sports nutrition beverages, and meat analog formulations.

Soy Protein Concentrates contain 65–70% protein on a dry basis and are the workhorse of the animal feed alternative protein segment, with cost efficiency and demonstrated digestibility advantages over raw soybean meal in monogastric species-particularly young piglets and poultry-where trypsin inhibitors and lectins in unprocessed soy create performance penalties.

Fermented Soy Protein is a rapidly growing sub-category where microbial fermentation is applied to soy substrates to further reduce anti-nutritional factors, improve digestibility coefficients, and add functional attributes valued in food and aquafeed applications.

Duckweed Protein is an emerging subsegment with commercial scale-up constrained by the April 2029 exclusivity window following the April 2024 EU novel food authorization.

Others within plant-based include pea protein-experiencing rapid capacity expansion-fava bean protein, hemp protein, oat protein, and rice protein. Pea protein has captured substantial R&D investment because its non-GMO positioning, allergen profile, and functional neutrality make it commercially versatile across multiple applications.

Insect-Based

The insect-based segment is projected to rise from USD 7.3 billion in 2025 to USD 20.5 billion by 2035 at approximately 10.2% CAGR. Its main commercial route is feed, especially aquaculture, poultry, and petfood, where black soldier fly meal can be evaluated against fishmeal and specialty protein inputs rather than against low-cost commodity protein alone.

Regulation continues to widen the addressable market. The United States finalized ingredient definitions for dried black soldier fly larvae for broiler, layer, and swine diets in August 2024. In Europe, UV-treated whole *Tenebrio molitor* larval powder was authorized as a novel food in January 2025. However, approvals do not resolve the cost of production. The segment's commercial discipline has become more visible following Ynsect's failure, while Innovafeed's September 2025 agreement with BioMar and Auchan to commercialize black soldier fly meal for shrimp feed in Ecuador provided a more demand-linked route to scale.

Microbial-Based

Microbial-based protein is the fastest-growing source category, projected to expand from USD 18.5 billion in 2025 to USD 68.7 billion by 2035 at approximately 13.2% CAGR. The segment includes bacterial single-cell protein, yeast, algae, and fungal mycoprotein. Its strategic attraction lies in production systems that can operate with limited agricultural land and offer tailored nutritional or functional attributes.

Gas fermentation is gaining importance in feed and petfood. Calysta's FeedKind protein is produced from *Methylococcus capsulatus* at the 20,000-tonne-per-year Calysseo facility in China. Aerbio's Netherlands pilot facility began producing Proton single-cell protein from carbon dioxide and hydrogen in August 2024, with output above 200 kg per month. These assets demonstrate technical progress, but commercial success depends on moving from pilot output to competitively utilized industrial capacity.

Bacteria within microbial-based primarily encompasses single-cell protein produced by hydrogen-oxidizing or methanotrophic bacteria, offering the lowest theoretical land-use footprint of any protein production system with 65–70% crude protein content.

Yeast is the most commercially mature subcategory, with yeast-derived protein produced at industrial scale for both food and feed applications. Lallemand's YELA PROSECURE hydrolyzed yeast has demonstrated in peer-reviewed trials that 3% inclusion can fully replace 4% porcine blood plasma during the prestarter phase while delivering equivalent growth performance and reduced mortality.

Algae encompasses both microalgae and macroalgae, with the EU's EIC allocating EUR 50 million to algae and precision-fermentation scale-up in its 2024 and 2025 work programmes.

Fungi includes filamentous fungi and mycoprotein. Fungal protein has advanced through regulatory milestones: the U.S. Food and Drug Administration closed GRAS Notice 1117 for mycelial biomass from *Neurospora crassa* in July 2024. Continuous-fermentation modeling suggests mycoprotein can reach beef-protein price parity on a protein-equivalent basis under favorable operating conditions.

Others

The Others segment is expected to increase from USD 5.1 billion in 2025 to USD 9.6 billion by 2035 at approximately 5.6% CAGR. This category includes emerging protein platforms, including cultivated protein, where commercialization remains constrained by production economics and limited operating-scale evidence.

By Application

Food

Food applications are projected to increase from USD 100.8 billion in 2025 to USD 307.0 billion by 2035 at approximately 11.0% CAGR. Meat analogs remain important, but the higher-value opportunity extends to dairy alternatives, bakery, beverages, snacks, and nutrition products. Plant-based dairy has shown particular channel resilience: plant-based milk held a 13% pound share of U.S. foodservice broadline milk sales and recorded 14% volume growth in 2024.

Ingredient functionality increasingly determines which source succeeds in each food use. Fava bean protein supports foaming and emulsification in bakery and dairy-alternative formulations, while high-moisture extrusion enables fibrous textures in meat analogs. Kerry and Ojah launched four clean-label chicken-alternative formats in November 2024, targeting food manufacturers seeking shorter ingredient lists and varied texture formats.

Meat Analogs are the flagship food subcategory, encompassing plant-based burgers, sausages, nuggets, strips, and pulled-meat formats, as well as mycoprotein-based products.

Bakery is a high-volume, price-sensitive channel where plant proteins function primarily as structural and nutritional enhancement agents, driven by consumer demand for high-protein claims.

Dairy Alternatives include plant-based milks, yogurts, cheeses, and ice cream. Global retail sales of plant-based milk, yogurt, ice cream, and cheese reached an estimated USD 28.6 billion in 2024.

Cereals and Snacks represent a growing channel for protein fortification, benefiting from clean-label compatibility and sports nutrition consumer segment growth.

Beverages include ready-to-drink protein shakes, fortified plant milks, sports recovery beverages, and functional nutrition drinks, where soy protein isolate and pea protein isolate are dominant ingredients.

Others within food include ready-to-eat meals, fermented soy products, nutritional supplements, and novel food categories.

Animal Feed

Animal feed is projected to grow from USD 6.9 billion in 2025 to USD 11.3 billion by 2035 at approximately 4.3% CAGR. Its lower value growth reflects commodity-like pricing and established incumbent proteins, but the segment provides an important commercialization path for insect, microbial, and processed plant proteins.

Aquaculture and petfood offer comparatively attractive entry points because they place a higher value on digestibility, fatty-acid profiles, supply security, and sustainability claims. Calysta and Marsapet launched a dog food containing FeedKind Pet protein in February 2025. In swine nutrition, Lallemand's YELA PROSECURE has demonstrated that a 3% inclusion level can replace 4% porcine blood plasma in prestarter diets while maintaining growth performance and reducing mortality.

Poultry represents the largest animal-feed application, with broiler and layer diets accounting for the most significant volume, given that chickens represent approximately one-third of all livestock meat produced globally.

Swine is segmented by life stage: Starter, Grower, and Sow. The starter phase is the highest-value application for specialty alternative proteins.

Cattle includes Dairy cows and Calf segments, with specialty protein concentrates most relevant in the pre-ruminant calf segment.

Aquaculture is the fastest-growing application within animal feed for alternative proteins, driven by the global aquaculture industry's structural need to reduce fishmeal dependency.

Petfood is a rapidly growing and premium-priced sub-segment where alternative protein ingredients command margins often two to three times higher than in conventional livestock feed.

Equine remains a niche segment where specialty protein digestibility requirements create opportunities for ultra-digestible soy protein concentrates and fermented proteins.

Others within animal feed include aquatic invertebrates, farmed insects for feed, and specialty applications.

Food applications will continue to capture most value because branding, sensory performance, and product innovation allow greater price realization. Feed will remain essential as a volume outlet and qualification pathway, particularly for insect and microbial proteins. Producers that can validate performance in aquaculture, petfood, or young-animal diets may establish operating revenue before attempting broad food-market expansion. That sequencing is less capital intensive than building capacity solely for mass-market meat analogs.

Alternative Protein Market Regional Analysis

North America

North America is projected to increase from USD 18.1 billion in 2025 to USD 49.4 billion by 2035 at approximately 9.8% CAGR. The United States combines substantial plant-based retail distribution with growing regulatory access for mycoprotein and insect-feed ingredients. Retail softness in plant-based meat demonstrates that the region's next stage depends on improved consumer value rather than market awareness alone ^{[7]Good Food Institute, 2024 State of Alternative Proteins, April 2025, gfi.org}.

Canada provides an ingredient-processing and innovation base. Protein Industries Canada supported a CAD 24.5 million project involving Roquette, Prairie Fava, BioNeutra, and Plant Up to develop pea- and fava-based food products and improve processing efficiency ^{[8]Food in Canada, Protein Industries Canada, Roquette, Prairie Fava, BioNeutra, Plant Up partner, May 2024, foodincanada.com}. This supports domestic value addition in pulse-producing regions rather than reliance on imported finished ingredients.

U.S.

U.S. retail plant-based sales totaled USD 8.1 billion in 2024, down 4% in dollars and 5% in units, reflecting consumer price sensitivity rather than structural demand retreat. Regulatory access has expanded: FDA GRAS Notice 1117 for mycelial biomass from Neurospora crassa was closed in July 2024, and AAFCO finalized ingredient definitions for dried black soldier fly larvae for broiler, layer, and swine diets in August 2024.

Canada

Canada benefits from Protein Industries Canada's programming, facilitating over CAD 1 billion in plant-based value chain investment since 2019, with continued expansion of domestic pea and fava bean protein processing infrastructure.

Europe

Europe is expected to grow from USD 27.7 billion in 2025 to USD 80.8 billion by 2035 at approximately 10.5% CAGR. The region combines regulatory sophistication, strong sustainability-related demand, and significant ingredient-processing investment. Germany has approached retail price parity in plant-based meat more closely than other surveyed European markets, while the United Kingdom has committed GBP 75 million to alternative-protein innovation since 2021.

The regional investment environment remains uneven. European alternative-protein research investment reached EUR 290 million in 2023 but declined to approximately EUR 236 million in 2025, against an estimated annual requirement of EUR 690 million.

Germany

Germany is the most developed national market, the only country among six surveyed in 2024 where plant-based meat substitutes approached retail price parity with conventional meat.

UK

UK committed GBP 75 million in government alternative protein investment since 2021.

France

France positioned itself as a center of insect protein technology, though Ynsect's liquidation has dampened the narrative, while Innovafeed's BioMar-Auchan shrimp-feed partnership signals continued commercial development.

Spain and Italy represent mid-sized markets where Mediterranean dietary traditions support higher per-capita legume and plant-based protein consumption.

Rest of Europe

Rest of Europe encompasses rapidly growing markets in the Netherlands, Denmark, Belgium, and the Nordic countries.

Asia Pacific

Asia Pacific is the largest regional market, rising from USD 50.4 billion in 2025 to USD 159.3 billion by 2035 at approximately 11.4% CAGR. The region's scale is supported by food consumption, feed demand, aquaculture, and established familiarity with soy- and fermentation-based foods. India's BioE3 and Bio-RIDE policies include approximately USD 1.1 billion in support through 2026. Australia's approval of cultivated quail in 2025 and South Korea's finalized cultivated-meat approval process in 2024 demonstrate that the region is also becoming a consequential regulatory test bed.

China

China is the largest national market in the region, with a large aquafeed sector creating structural demand for alternative protein feed ingredients reducing reliance on imported fishmeal.

India

India is projected to be the fastest-growing national market, with the world's largest vegetarian population, longstanding pulse and legume traditions, and a rapidly expanding urban middle class.

Japan

Japan combines one of the world's oldest tofu and soy-based food markets with a highly developed food technology sector and increasing institutional interest in alternative proteins for food security.

Australia

Australia received FSANZ approval for a cultivated quail product in 2025, making it the third jurisdiction globally to greenlight a cultivated meat product.

South Korea

South Korea finalized a cultivated meat approval process in 2024, positioning itself alongside Singapore as an early regulatory enabler.

Rest of Asia Pacific

Rest of Asia Pacific includes Southeast Asian markets where protein demand growth from population expansion and rising income per capita is the primary driver.

Latin America

Latin America is projected to grow from USD 8.3 billion in 2025 to USD 21.9 billion by 2035 at approximately 9.4% CAGR. Brazil anchors the region through its large food and agricultural base. Retail volume of plant-based meat and seafood alternatives in Brazil increased 17% in 2025, while consumer spending reached BRL 1.9 billion.

Brazil

Brazil leads the regional market, combining its position as the world's largest soybean exporter with growing domestic alternative protein consumer demand.

Mexico

Mexico represents the second-largest Latin American market, driven by QSR channel penetration and urban middle class adoption.

Argentina

Argentina is the third pillar, with strong agri-processing infrastructure for soy and legumes.

Rest of Latin America

Rest of Latin America includes Colombia, Peru, Chile, and other markets where local fermented food traditions support early consumer familiarity.

Middle East and Africa

The Middle East and Africa market is projected to rise from USD 3.1 billion in 2025 to USD 7.0 billion by 2035 at approximately 7.6% CAGR. Food security, import dependence, and water constraints create a strategic rationale for alternative protein investment, particularly in the Gulf.

Saudi Arabia

Saudi Arabia is actively diversifying its food security strategy through Vision 2030, creating policy tailwinds for alternative protein market entry.

South Africa

South Africa is expected to register the highest national CAGR within the MEA region from 2024 to 2030, with an active food technology startup sector and an established black soldier fly insect protein industry.

UAE

UAE is the most developed national market, with an urban affluent consumer base with high exposure to international food trends and a strong food service culture.

Rest of Middle East and Africa

Rest of Middle East and Africa includes markets where affordability and limited local manufacturing capacity constrain immediate mass-market adoption, with initial demand more likely in foodservice, premium retail, and specialized feed applications.

Europe and North America remain important for formulation innovation, regulation, and premium-market validation, even where retail growth has moderated. Latin America can combine domestic agricultural feedstocks with growing consumer interest, while the Middle East and Africa may reward technologies that address import dependence and resource constraints. Companies with a regional manufacturing strategy, rather than a single global product proposition, will be better positioned to navigate these divergent demand conditions.

Alternative Protein Market Share & Competitive Landscape

The competitive landscape spans agricultural processors, specialist fermentation companies, insect-protein developers, nutrition suppliers, and food-ingredient manufacturers. Competitive advantage is increasingly determined by access to feedstock, production infrastructure, regulatory capability, application expertise, and customer qualification rather than by protein-source positioning alone.

Hamlet Protein A/S supplies enzyme-treated soy protein products for young-animal nutrition. Its HP 300, HP 100, and HP 800 Booster products are positioned around digestibility and reduced anti-nutritional factors in piglet, poultry, and calf diets; the company operates production sites in Denmark and the United States ^{[9]Hamlet Protein, Market Outlook 2024: Hamlet Protein CEO Discusses Slower Growth, Regional Variances, and ESG Impact, 2024, hamletprotein.com}.

E.I. Du Pont De Nemours and Company remains relevant through its historical role in specialty materials, food ingredients, and protein-processing technologies.

Archer Daniels Midland Company combines agricultural origination, protein processing, extrusion capacity, and innovation resources. Its Decatur expansion strengthens its ability to serve both commodity-adjacent protein ingredients and higher-value textured applications.

Nordic Soya Oy produces rapeseed protein concentrate through water-ethanol extraction. Its soy-free positioning and amino-acid profile target animal-nutrition users seeking alternatives to conventional soy-derived proteins.

Deep Branch Biotechnology operates under the Aerbio identity following its reorganization. Its platform converts carbon dioxide and hydrogen into single-cell protein, with pilot operations in the Netherlands providing a foundation for scale-up.

CHS Inc. expands protein availability through soybean-meal crushing and pulse processing. Its investment in the Myrtle Grove export facility supports soybean-meal logistics, while its pulse business serves food, export, and petfood markets.

Agriprotein GmbH operates in black soldier fly protein, oil, and fertilizer products for feed and petfood applications.

Darling Ingredients participates in the broader protein and nutritional-ingredient value chain through animal by-product processing and ingredient commercialization.

Innovafeed has pursued a staged black soldier fly scale-up model. Its commercial partnership with BioMar and Auchan for shrimp feed in Ecuador illustrates an application-led route to insect-protein demand, while its Decatur pilot pause demonstrates ongoing adjustment of North American operating models,.

Ynsect illustrates the financial risks of capital-intensive insect production. The company's judicial recovery and later liquidation underline the importance of cost control, feedstock access, and confirmed offtake before large-scale infrastructure deployment,.

Angel Yeast participates in food and feed protein markets through yeast-derived protein and fermentation capabilities.

Calysta Inc. produces FeedKind single-cell protein through the Calysseo facility in China. Its commercial entry into petfood with Marsapet broadens its route beyond aquafeed,.

Lallemand, Inc. supplies yeast-based ingredients for animal nutrition. Its validated hydrolyzed-yeast applications demonstrate the value of performance evidence in high-value prestarter diets.

AB Mauri applies yeast and fermentation capabilities to alternative-protein and animal-nutrition ingredient opportunities.

Ingredion combines formulation expertise with plant-protein supply. Its partnership with Lantmännen includes a planned pea protein isolate facility in Sweden, expected to be completed in 2027.

Beneo GmbH is building faba-bean protein capacity in Germany and targets meat-replacement, dairy-alternative, bakery, and sports-nutrition applications.

Roquette Frères is expanding its pulse-protein portfolio through fava-bean and pea-protein ingredients, including NUTRALYS Fava S900M.

Kerry Group supplies textured plant-protein solutions and has expanded its clean-label chicken-alternative formats with Ojah.

DuPont Nutrition Biosciences operates within the broader nutrition-and-biosciences ingredient landscape and supports protein formulations through functional food-ingredient capabilities.

Puris specializes in non-GMO pea proteins and vertically integrated sourcing for plant-based food, dairy-alternative, sports-nutrition, and foodservice applications.

Recent Industry Developments

January 2025 - The European Union authorized UV-treated whole *Tenebrio molitor* larval powder as a novel food.

February 2025 - Calysta and Marsapet launched dog food containing FeedKind Pet protein.

February 2025 - Ynsect entered judicial recovery; the company subsequently moved into liquidation during 2025,.

Q1 2025 - ADM completed the expansion of its Decatur soy protein complex.

Q2 2025 - Beneo opened its faba bean protein concentrate facility in Offstein, Germany.

August 2025 - Innovafeed paused operations at its North American Insect Innovation Center pilot facility in Decatur after completing research and development validation.

September 2025 - BioMar, Innovafeed, and Auchan announced a partnership to commercialize black soldier fly meal in shrimp-feed supply chains in Ecuador.